CLINICAL AND MRI PREDICTORS OF INTERNAL NEUROFIBROMA GROWTH IN NEUROFIBROMATOSIS TYPE 1

$435,956FY2021Defense Health AgencyDOD

The General Hospital Corporation

Investigators